14-day Premium Trial Subscription Sign Up For FreeGet Free

Capricor Therapeutics Stock Forecast NASDAQ:CAPR

Price Target and Analyst Ratings

Most Recent Rating

Maxim Group is very positive about CAPR and gave it a "Buy" rating on August 07, 2020. The price target was set to $12.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2020-08-07 Buy Initiated by Maxim Group $6.53 $12.00
2020-05-16 Buy Initiated by Maxim Group $5.99 $12.00
2020-04-30 Buy Reiterated by Maxim Group $7.00 $10.00

CAPR Stock Trend

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $5.01 will firstly indicate a slower falling rate, but may be the first sign of a trend shift.

Given the current short-term trend, the stock is expected to fall -10.69% during the next 3 months and, with a 90% probability hold a price between $3.21 and $4.48 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-23 $3.58 $4.29 $5.00
2021-09-24 $3.57 $4.28 $4.99
2021-09-27 $3.56 $4.27 $4.98
2021-09-28 $3.55 $4.26 $4.97
2021-09-29 $3.54 $4.25 $4.96
2021-09-30 $3.53 $4.24 $4.95
2021-10-01 $3.52 $4.23 $4.94
2021-10-04 $3.51 $4.22 $4.93
2021-10-05 $3.50 $4.22 $4.93
2021-10-06 $3.50 $4.21 $4.92
2021-10-07 $3.49 $4.20 $4.91
2021-10-08 $3.48 $4.19 $4.90
2021-10-11 $3.47 $4.18 $4.89
2021-10-12 $3.46 $4.17 $4.88
2021-10-13 $3.45 $4.16 $4.87
2021-10-14 $3.44 $4.15 $4.86
2021-10-15 $3.43 $4.14 $4.85
2021-10-18 $3.42 $4.13 $4.84
2021-10-19 $3.41 $4.12 $4.83
2021-10-20 $3.40 $4.11 $4.82
2021-10-21 $3.39 $4.10 $4.81
2021-10-22 $3.38 $4.09 $4.80
2021-10-25 $3.37 $4.08 $4.79
2021-10-26 $3.36 $4.07 $4.78
2021-10-27 $3.35 $4.06 $4.77
2021-10-28 $3.34 $4.05 $4.76
2021-10-29 $3.33 $4.04 $4.75
2021-11-01 $3.32 $4.03 $4.74
2021-11-02 $3.31 $4.02 $4.73
2021-11-03 $3.31 $4.02 $4.73

About Capricor Therapeutics

Capricor Therapeutics Capricor Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company’s development stage drug candidates for cardiovascular diseases include CAP-1002 and enderitide, which are in Phase II clinical trials, as well as CAP-1001, which has completed Phase I clinical trial; and CU-NP and CSps. It is also developing E... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT